NantHealth, Inc. Quarterly Operating Income (Loss) in USD from Q1 2015 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
NantHealth, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2015 to Q3 2023.
  • NantHealth, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$10.5M, a 25.8% increase year-over-year.
  • NantHealth, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$44.4M, a 11.5% increase year-over-year.
  • NantHealth, Inc. annual Operating Income (Loss) for 2022 was -$51.3M, a 25.5% decline from 2021.
  • NantHealth, Inc. annual Operating Income (Loss) for 2021 was -$40.9M, a 55.7% decline from 2020.
  • NantHealth, Inc. annual Operating Income (Loss) for 2020 was -$26.3M, a 23.7% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$44.4M -$10.5M +$3.65M +25.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-22
Q2 2023 -$48.1M -$8.73M +$2.98M +25.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-22
Q1 2023 -$51.1M -$12.2M +$257K +2.06% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$51.3M -$13M -$1.11M -9.31% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-14
Q3 2022 -$50.2M -$14.2M -$3.09M -27.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-22
Q2 2022 -$47.1M -$11.7M -$3.12M -36.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-22
Q1 2022 -$44M -$12.5M -$3.11M -33.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$40.9M -$11.9M -$5.1M -75.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-14
Q3 2021 -$35.8M -$11.1M -$4.24M -62% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$31.6M -$8.59M -$1.78M -26.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 -$29.8M -$9.37M -$3.51M -59.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$26.3M -$6.76M -$2.17M -47.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-25
Q3 2020 -$24.1M -$6.84M -$51K -0.75% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$24M -$6.81M +$4.1M +37.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$28.1M -$5.86M +$4.42M +43% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$32.6M -$4.59M +$4.67M +50.5% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-28
Q3 2019 -$37.2M -$6.78M +$5.04M +42.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$42.3M -$10.9M +$2.96M +21.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$45.2M -$10.3M +$5.47M +34.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$50.7M -$9.26M +$7.98M +46.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 -$58.7M -$11.8M +$4.21M +26.3% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-28
Q2 2018 -$62.9M -$13.9M +$927K +6.27% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-28
Q1 2018 -$63.8M -$15.7M +$4.08M +20.6% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-28
Q4 2017 -$67.9M -$17.2M +$4.05M +19% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$72M -$16M +$6.39M +28.5% Jul 1, 2017 Sep 30, 2017 10-K 2019-04-01
Q2 2017 -$78.3M -$14.8M +$38.2M +72.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-04-01
Q1 2017 -$117M -$19.8M +$3.97M +16.7% Jan 1, 2017 Mar 31, 2017 10-K 2019-04-01
Q4 2016 -$120M -$21.3M -$6.29M -41.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$114M -$22.4M +$1.2M +5.07% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-16
Q2 2016 -$115M -$53M -$35.6M -205% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-16
Q1 2016 -$79.8M -$23.8M -$8.86M -59.3% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-16
Q4 2015 -$70.9M -$15M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$23.6M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-31
Q2 2015 -$17.3M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-31
Q1 2015 -$14.9M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.